Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 448-452

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 1, randomized, dose‐ranging study of GS‐5816, a once‐daily NS5A inhibitor, in patients with genotype 1–4 hepatitis C virus

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 1011-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma

By Knox A   Langan J   Martinot J-B   Gruss C   Häfner D  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2387-2394

Informa Healthcare

Access to resources Recommend Favorite

Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults

By Howard Danny R.   Haribhakti Rajiv   Kittner Barbara   Agrawala Praful  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 769-776

Informa Healthcare

Access to resources Recommend Favorite

Tramadol and delirium

By  

ANAESTHESIA, Vol. 70, Iss. 5, 2015-05 ,pp. : 632-633

John Wiley & Sons Inc

Access to resources Recommend Favorite